Thalen Biotech Consultancy SRL
Thalen Biotech Consultancy reported total assets of 215,550 € at the end of the 2025 financial year (annual accounts filed with the NBB on 24 Jun 2026).
The score of Thalen Biotech Consultancy shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity -9 % Total assets -1 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Thalen Biotech Consultancy's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Net result | 166,089 € | ||||
| Equity | 18,550 € | ||||
| Cash | 167,800 € | ||||
| EBITDA | 221,087 € | ||||
| Total assets | 215,550 € |
Filed annual accounts
- Year ended 31 Dec 2025filed on 24 Jun 2026
- Year ended 31 Dec 2024filed on 07 Jul 2025
- Year ended 31 Dec 2023filed on 26 Jun 2024
- Year ended 31 Dec 2022filed on 22 Jun 2023
- Year ended 31 Dec 2021filed on 04 Jul 2022
Thalen Biotech Consultancy's financial analysis
- Solvency8.6%sector median: 58.2%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Thalen Biotech Consultancy
Thalen Biotech Consultancy's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0607.985.607
- VAT number
- BE0607985607
- Peppol
- Registered · 0208:0607985607 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 25 Mar 2015
- Registered office
- 7911 Frasnes-lez-Anvaing
- Latest accounts
- 2025 · filed on 24 Jun 2026
- Activity
- Research and experimental development on biotechnology (NACE 72101)
Thalen Biotech Consultancy (SRL) has been based in Frasnes-lez-Anvaing since 2015, active in: research and experimental development on biotechnology. For 2025, it reports a net profit of 166,089 € and equity of 18,550 €; its revenue is not published. Its solvency stands at 8.6%, below the median of its sector (58.2%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Thalen Biotech Consultancy
Companies in the same business, of comparable size and area, outside its group.
- Bio-Perspectives Research and experimental development on natural sciences and engineering Ixelles · balance sheet 206,760 €
- Opero Research and experimental development on natural sciences and engineering Grimbergen · balance sheet 225,981 €
- CBaBC Research and experimental development on natural sciences and engineering Destelbergen · balance sheet 249,523 €
- Thomas De Beer Consulting Research and experimental development on natural sciences and engineering Deinze · balance sheet 252,275 €
- ProteoFormiX Research and experimental development on natural sciences and engineering Vorselaar · balance sheet 182,817 €
- Perpetuum CropScience Research and experimental development on natural sciences and engineering Beveren-Kruibeke-Zwijndrecht · balance sheet 181,346 €
- Certor Research and experimental development on natural sciences and engineering Mechelen · balance sheet 505,224 €
- Clino Consult Research and experimental development on natural sciences and engineering Beveren-Kruibeke-Zwijndrecht · balance sheet 191,749 €
Frequently asked questions about Thalen Biotech Consultancy
What is the revenue of Thalen Biotech Consultancy?
Thalen Biotech Consultancy files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Thalen Biotech Consultancy?
In Belgium, the VAT number is the company number prefixed with BE: BE0607985607 for Thalen Biotech Consultancy, if the company is VAT-registered. Its company number (CBE) is 0607.985.607.
Where is the registered office of Thalen Biotech Consultancy?
According to the CBE register, the registered office of Thalen Biotech Consultancy is in 7911 Frasnes-lez-Anvaing.
What is the equity of Thalen Biotech Consultancy?
At the close of the 2025 financial year, the equity of Thalen Biotech Consultancy amounts to 18,550 €, a solvency of 8.6% of total assets.
Who manages Thalen Biotech Consultancy?
The register lists 2 active mandates at Thalen Biotech Consultancy. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Thalen Biotech Consultancy
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →